High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

May 13, 2025

Study Completion Date

May 13, 2025

Conditions

Chronic Kidney Disease 5D

Interventions

DRUG

Liposomal curcumin

participants will consume the product ad libitum for the 24 treatments.

DRUG

Food colorant

participants will consume the product ad libitum for the 24 treatments as a placebo.

Trial Locations (1)

University of Florida, Gainesville

All Listed Sponsors

lead

University of Florida

OTHER

NCT06381076 - High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis. | Biotech Hunter | Biotech Hunter